Antiandrogen ICI 176,334 does not prevent development of androgen insensitivity in S115 mouse mammary tumour cells
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 36 (5) , 385-389
- https://doi.org/10.1016/0022-4731(90)90078-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation functionCell, 1988
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988
- Interaction of different steroid hormones during progression of tumour cells to steroid autonomyInternational Journal of Cancer, 1987
- Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureEuropean Journal of Cancer and Clinical Oncology, 1987
- Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptorsCell, 1987
- ICI 176,334: A NOVEL NON–STEROIDAL, PERIPHERALLY SELECTIVE ANTIANDROGENJournal of Endocrinology, 1987
- Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamideThe Prostate, 1987
- Androgen regulates MMTV RNA in the short-term in S115 mouse mammary tumour cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation.The Journal of cell biology, 1984
- The role of receptors in the steroidal regulation of tumour cell proliferationJournal of Steroid Biochemistry, 1976